ESC TV

Interventional cardiology

• The PRODIGY Trial, a randomized comparison of 6 versus 24 months clopidogrel therapy in all comer patients undergoing percutaneous coronary intervention (Marco VALGIMIGLI,Ferrara)
• Bern-Rottedarm Cohort Study - Newer generation everolimus-eluting stents eliminate the risk of very late stent thrombosis compared with early generation sirolimus-eluting and paclitaxel-eluting stents (Lorenz RÄBER, Bern)
• ESC Guidelines - Acute coronary syndrome and non ST-elevation (Christian HAMM, Bad Nauheim and Jean-Pierre BASSAND, Besançon)
• First results from FRANCE II, the French registry aortic national corevalve and Edwards registry II (Martine GILARD, Brest)

Heart Failure

• Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival (Bertini MATTEO, Bologna)
• The SHIFT-Echocardiography sub-study: Selective heart rate reduction with Ivabradine improves left ventricular remodeling and function: insights from (Jean-Claude TARDIF, Montreal)
• SHIFT Quality of life sub-study: Relationship between heart rate and health related quality of life  (Inger EKMAN, Goteborg)
• Correction of mitral regurgitation by mitraclip in non-responders to cardiac resynchronization therapy improves symptoms and promotes reverse remodeling (Auricchio ANGELO,Lugano)

Atrial fibrillation

• The GARFIELD registry, a multicentre international registry of patients newly diagnosed with atrial fibrillation at risk of stroke (Ajay KAKKAR, London)
• New evidences beyond ESC guidelines in AF, will catheter ablation of atrial fibrillation withstand the test of randomised studies? (Sabine ERNST, London)
• The ARISTOTLE Trial, efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18 202 patients with atrial fibrillation (Christopher GRANGER, Durham and Lars WALLENTIN, Uppsala)

Hypertension

• Renal nerve ablation, ready for prime time? (Henry KRUM, Melbourne)
• Impact of ACE and angiotensin II receptor blockers on all-cause mortality in hypertension trials (Michel BERTRAND, Lille)
• Blood pressure variability (Denis CLEMENT, Ghent)

ICD and telemonitoring

• The prospective randomized EVATEL study: remote follow-up of patients implanted with an ICD (Philippe MABO, Rennes)
• ECOST study, safety of implantable cardioverter defibrillator follow-up using remote monitoring: a randomized controlled trial (Salem KACET, Lille)

Prevention

• The PURE study, the prevention gaps in 17 low, middle and high income countries involving over 150,000 people (Salim YUSUF, Hamilton)

• The Homburg Cream and Sugar study, a prospective evaluation of post-prandial triglycerides and cardiovascular events in patients with coronary artery disease (Ulrich LAUFS, Homburg)
• ESC New Guidelines on dyslipidemias (Zeljko REINER, Zagreb)

CVD and Pregnancy

• ESC New Guidelines on cardiovascular disease during pregnancy (Vera REGITZ-ZAGROSEK, Berlin)
• The ESC Pregnancy and Heart Diseases registry (Jolien ROOS-HESSELINK, Rotterdam)

Tuesday 30 August 2011 - Day 4

Best of ESC 2011 Hot Line III - Acute Coronary Syndromes

• PRODIGY - Randomized comparison of 6 versus 24 months clopidogrel therapy after PCI - Marco VALGIMIGLI, Ferrara
• Bern-Rotterdam Cohort Study - Newer generation DES eliminate the risk of very late stent thrombosis compared with early generation DES - Lorenz RÄBER, Bern

Images from ESC 2011
Clinical trial update: The SHIFT-Echocardiography sub-study - Jean-Claude TARDIF, Montreal
New ESC Guidelines: Dyslipidemias - Zeljko REINER, Zagreb
From Paris to Munich: Michel KOMAJDA, President of the European Society of Cardiology

Monday 29 August 2011 - Day 3

Best of ESC 2011 Hot Line II - Interventional and Device Treatments

• EVATEL - Remote follow-up of patients implanted with an ICD - Philippe MABO, Rennes
• CREDO-Kyoto PCI/CABG registry Cohort-2 - Comparison of 3 year outcome after PCI and CABG stratified by the SYNTAX score in patients with triple vessel CAD - Hiroki SHIOMI, Kyoto

Atout cœur, à tout âge: Public event on the "Paris de l'hôtel de ville de Paris"

Clinical Registry Highlight : GARFIELD - Multicentre international registry of patients newly diagnosed with atrial fibrillation at risk of stroke - Ajay KAKKAR, London

ESC Studio: The new Heart Score - Ian GRAHAM, Dublin

New ESC Guidelines: Peripheral artery disease - Victor ABOYANS, Limoges

Sunday 28 August 2011 - Day 2

Best of ESC 2011 Hot Line I

• Cardiovascular Risk and Complications
• ARISTOTLE - Apixaban versus Warfarin in Patients with Atrial Fibrillation – Christopher GRANGER, Durham and Lars WALLENTIN, Uppsala
• PURE - The prevention gaps in 17 low, middle and high income countries involving over 150,000 people - Salim YUSUF, Hamilton 

ESC 2011 Spotlight « Controversies issues in cardiology »

• Left atrial appendage closure in secondary stroke prevention - Horst SIEVERT, Frankfurt and Francisco MARIN, Murcia

Mitral Valve Repair and CRT resistant HF - Angelo AURICCHIO, Lugano
Meet the 2011 Gold Medalist - Henri KULBERTUS, Liège

Saturday 27 August  - Day 1